Bloomage Biotech(SH:688363) 中国基金报·2025-07-26 08:31Core Viewpoint - Huaxi Biological has officially responded to false information circulating on online platforms, claiming that the content is fabricated and maliciously distorts facts, which has severely damaged the company's reputation. The company has reported the matter to the public security authorities and will pursue legal action against the spreaders of rumors [1][2]. Summary by Sections - The company discovered serious false information about itself on online platforms, which was confirmed to be fabricated and published on an overseas website. The nature of the content includes political rumors, which the company deems extremely malicious [2]. - The individual responsible for the false information, identified as Li, previously served as the marketing director at Huaxi Xinyu Investment Co., Ltd. Li had a history of embezzlement, having fraudulently obtained 9 million yuan that was supposed to be paid to a brokerage firm. This incident was uncovered during an annual report review [2]. - Following the discovery of Li's actions, the company reported the case to the public security authorities, which led to a criminal prosecution based on the embezzlement charge. During the investigation, Li attempted to mitigate his punishment by writing an apology letter, but the company refused to entertain any additional compensation demands beyond the return of the embezzled funds [2]. - As of July 25, Huaxi Biological's stock closed at 53.83 yuan per share, with a market capitalization of 25.9 billion yuan [2].